Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

This study has been completed.

First Received: January 16, 2001 Last Updated: June 23, 2005 History of Changes

Sponsors and Collaborators:	National Center for Research Resources (NCRR) Children's Hospital of Philadelphia
Information provided by:	National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier:	NCT00008736

Purpose

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Condition	Intervention	Phase
Infant, Newborn, Diseases	Drug: metoclopramide	Phase II

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized
Official Title:	Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Resource links provided by NLM:

MedlinePlus related topics: Premature Babies

Drug Information available for: Metoclopramide hydrochloride Metoclopramide

U.S. FDA Resources

Eligibility

Ages Eligible for Study:	up to 1 Month
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00008736

Locations

United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104

Sponsors and Collaborators

National Center for Research Resources (NCRR)

Children's Hospital of Philadelphia

More Information

No publications provided

Study ID Numbers:	NCRR-M01RR00240-1724
Study First Received:	January 16, 2001
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00008736 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Center for Research Resources (NCRR):

Feeding intolerance
Infant, premature

Study placed in the following topic categories:

Neurotransmitter Agents
Dopamine
Antiemetics
Infant, Newborn, Diseases

Dopamine Agents
Peripheral Nervous System Agents
Metoclopramide

Additional relevant MeSH terms:

Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Gastrointestinal Agents
Antiemetics
Dopamine Antagonists
Metoclopramide

Pharmacologic Actions
Autonomic Agents
Therapeutic Uses
Infant, Newborn, Diseases
Dopamine Agents
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on July 02, 2009